ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物科技指數ETF-iShares Nasdaq
213.56
+2.73
1.29%
盤後:
214.49
0.9300
+0.44%
19:57 EDT
成交量:
268.16萬
成交額:
5.74億
市值:
107.42億
市盈率:
33.83
高:
215.61
開:
211.55
低:
211.06
收:
210.83
52周最高:
217.06
52周最低:
136.89
股本:
5,030.00萬
流通股本:
5,030.00萬
量比:
1.59
換手率:
5.33%
股息:
0.41
股息率:
0.19%
每股收益(TTM):
6.31
每股收益(LYR):
-1.4940
淨資產收益率:
24.54%
總資產收益率:
0.10%
市淨率:
1.32
市盈率(LYR):
-142.95
資料載入中...
總覽
公司
新聞資訊
公告
美國聯邦貿易委員會(FTC):安進專利申請收購交易受到反壟斷審查。
智通财经
·
08/21
Piper Sandler上調安進目標價至457美元
格隆汇
·
08/21
美國研究綜述-安進、Analog Devices、莫德納
路透中文
·
08/20
復宏漢霖盤中漲近8% 近期聯手山德士出海至多10款生物類似藥
新浪港股
·
08/20
福泰製藥(VRTX)股票8月19日收盤上漲4.48%:釋放什麼信號?
TradingKey中文
·
08/20
吉利德科學(GILD)股票8月19日盤中上漲3.66%:背後推手曝光
TradingKey中文
·
08/20
安進(AMGN)股票8月19日盤中上漲3.19%:背後推手曝光
TradingKey中文
·
08/20
再生元製藥旗下Pasatru獲歐洲藥品管理局審評,全球申報在即
美股速递
·
08/20
再生元製藥獲FDA批准:Pasatru(Garetosmab-Grts)上市,治療成人進行性骨化性纖維發育不良
美股速递
·
08/20
異動解讀|生物科技指數ETF-iShares Nasdaq盤中上漲5.1%,MNC併購加速疊加多重利好共振
行情直击
·
08/19
瑞穗上調安進目標價至352美元
格隆汇
·
08/19
駿利亨德森投資:專利到期倒逼藥企擴張 生物科技併購、IPO市場同步復甦
智通财经网
·
08/19
藥代違規進入診療區域!湘雅二醫院發藥品「停用函」,艾力斯、賽諾菲、安進、康蒂尼四藥企上「黑榜」
蓝鲸财经
·
08/19
TScan Therapeutics披露:安進將終止與其研究合作及許可協議
美股速递
·
08/19
吉利德科學(GILD)股票8月18日盤中上漲3.14%:背後推手曝光
TradingKey中文
·
08/19
argenx SE(ARGX)股票8月17日盤中上漲16.67%:關鍵驅動因素揭曉
TradingKey中文
·
08/18
EyePoint股價料將創下歷史最大跌幅,因其一款實驗性眼科藥物未能達到後期臨床試驗目標
路透中文
·
08/17
美股開盤 | 三大指數升跌不一,閃迪升逾3%,Argenx SE漲近9%
老虎资讯综合
·
08/17
EyePoint公司治療年齡相關性眼病的藥物晚期臨床試驗失敗,股價暴跌
路透中文
·
08/17
美股異動 | Argenx(ARGX.US)盤前升逾10% 自身免疫性肌炎藥物Vyvgart III期研究達主要終點
智通财经
·
08/17
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/IBB/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":213.56,"timestamp":1787342400000,"preClose":210.83,"halted":0,"volume":2681565,"hourTrading":{"tag":"盘后","latestPrice":214.49,"preClose":213.56,"latestTime":"19:57 EDT","volume":10048,"amount":2146390.3292,"timestamp":1787356664368,"change":0.93,"changeRate":0.004355,"amplitude":0.004355},"delay":0,"changeRate":0.012948821325238294,"floatShares":50300000,"shares":50300000,"eps":6.311863,"marketStatus":"未開盤","change":2.73,"latestTime":"08-21 16:00:00 EDT","open":211.55,"high":215.605,"low":211.06,"amount":573855312.23475,"amplitude":0.021558,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":210.83,"sharesOutstanding":49450000,"nav":213.623549,"aum":10681177450,"dividendRate":0.0019,"bidAskSpread":0.000342,"preHourTrading":{"tag":"盘前","latestPrice":211.5,"preClose":210.83,"latestTime":"09:19 EDT","volume":831,"amount":176015.5227,"timestamp":1787318399909,"change":0.67,"changeRate":0.003178,"amplitude":0.009464},"postHourTrading":{"tag":"盘后","latestPrice":214.49,"preClose":213.56,"latestTime":"19:57 EDT","volume":10048,"amount":2146390.3292,"timestamp":1787356664368,"change":0.93,"changeRate":0.004355,"amplitude":0.004355},"volumeRatio":1.5940632811712638,"impliedVol":0.2361,"impliedVolPercentile":0.576},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50300000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":1.5940632811712638,"shares":50300000,"dividePrice":0.4058,"high":215.605,"amplitude":0.021558,"preClose":210.83,"low":211.06,"week52Low":136.89,"pbRate":"1.32","psRate":"258.45","week52High":217.06,"institutionHeld":0,"latestPrice":213.56,"eps":6.311863,"divideRate":0.0019,"volume":2681565,"delay":0,"ttmEps":6.311863,"open":211.55,"prevYearClose":168.77,"prevWeekClose":198.26,"prevMonthClose":186.41,"prevQuarterClose":190.19,"fiveDayClose":198.26,"twentyDayClose":188.14,"sixtyDayClose":169.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661291370","title":"美國聯邦貿易委員會(FTC):安進專利申請收購交易受到反壟斷審查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291370","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:49","pubTimestamp":1787327356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HCA","AMGN","KEMQ","JHMT","PNQI","TRUC","CWC","ARB","GOOX","MSFY","BUYO","IBB","GXPT","MUSQ","LRGG","TBXU","RSPT","WEBX","JHCS","ORCZ","IXP","PBS","IEME","TGRW","NBCC","DRUP","PBE","MSFX","PJP","BWEB","GXPC","DISC","WEBL","BBH","GGTL","QQMG","BCTK","MNA","BIB","FCOM","XLCI","FTC","MRGR","EVNT","TDAQ","ONEQ","IBBQ","NBDS","EMQQ","IHF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250489","title":"Piper Sandler上調安進目標價至457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250489?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 15:20","pubTimestamp":1787296801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4566","BK4588","BK4139","IE00B2B36J28.USD","BK4581","PJP","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4534","LU0868494617.USD","LU1061106388.HKD","IE0009355771.USD","LU2089984988.USD","LU1983299246.USD","LU2242646821.SGD","SG9999001440.SGD","LU0109394709.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2242652126.USD","LU0889565916.HKD","BK4533","LU2468319806.SGD","LU1057294990.SGD","LU0320765992.SGD","UUP","LU1023059063.AUD","UDN","BK4599","LU0289739699.SGD","BK4585","LU2112291526.USD","BIB","IBBQ","LU0122379950.USD","IE00BFTCPJ56.SGD","AMGN","IE00B4R5TH58.HKD","TBXU","BBH","PBE","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043834","title":"美國研究綜述-安進、Analog Devices、莫德納","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043834","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660043834?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 15:49","pubTimestamp":1787212153,"startTime":"0","endTime":"0","summary":"美国研究综述-安进、Analog Devices、莫德纳路透8月20日-周四,华尔街证券分析师上调了多家在美国上市公司的评级和目标股价,其中包括安进、模拟设备公司和莫德纳。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4S44H0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3S45H60.SGD","LU0058720904.USD","LU1235294995.USD","LU2275660780.HKD","LU0154236417.USD","BK4130","LU0061475181.USD","IE00B4R5TH58.HKD","LU1951198990.SGD","ARTY","LU1066051225.USD","LU2347655073.USD","TBXU","LU0553294199.USD","LU1084165304.USD","LU1670710588.SGD","LU1720051017.SGD","IE00BN8TJ469.HKD","SG9999014005.SGD","LU2458330169.SGD","LU1066051811.HKD","SG9999014021.USD","LU0234572021.USD","SG9999015986.USD","LU1670711123.USD","LU0889565916.HKD","IE00B894F039.SGD","LU2129689605.HKD","LU0320765992.SGD","LU0320765646.SGD","LU1506573853.SGD","LU1935043536.SGD","LU0274383776.USD","BK4534","LU2237443465.HKD","IE0009355771.USD","BK4139","FHLC","LU2298322129.HKD","BK4568","CRWL","BK4141","IE0004091025.USD","LU0158827948.USD","LU0211331839.USD","BK4554","BK4605","BK4561","LU2517655291.USD","PJP","BK4504","SNOW","BK4023","LU1934455277.USD","BK4581","BK4566","LU0511384066.AUD","LU1291159041.SGD","IE00B5TLWC47.USD","LU1496350502.SGD","LU1804176565.USD","LU0170899867.USD","LU2360107325.USD","LU1732800096.USD","LU2023251221.USD","LU2322448957.HKD","BK4094","LU1674673691.USD","LU0823416689.USD","LU2468319806.SGD","BK4528","LU1489326972.SGD","LU1934455194.USD","LU0097036916.USD","LU2298321311.HKD","LU0545039389.USD","IGV","LU1699723380.USD","LU0070302665.USD","LU2125154778.USD","LU0057025933.USD","LU0738911758.USD","LU1989772840.SGD","LU1992135472.HKD","LU0052756011.USD","LU0690374961.EUR","AGNG","TRUH","LU0029864427.USD","CRWD","LU2357305700.SGD","LU1267930573.SGD","LU0823434583.USD","BK4599","IE00B19Z3581.USD","LU0965508806.USD","TJX","SG9999001176.SGD","IE0004445239.USD","LU1670627923.USD","LU0314104364.USD","IE00BDGV0183.EUR","LU1989764664.SGD","IE000M9KFDE8.USD","LU0868494708.USD","LU0980610538.SGD","IE00BMPRXQ63.HKD","ADI","PSWD","IE0034235188.USD","XLV","IDNA","IE0004086264.USD","LU0310799852.SGD","LU2361045086.USD","LU0726765562.USD","PCTY","LU1732799900.SGD","LU0719512351.SGD","LU1720051108.HKD","LU1941712348.USD","LU0081259029.USD","LU1162221912.USD","LU2265009873.SGD","IE000SO60NU8.SGD","LU1244550577.SGD","LU1670628061.USD","SG9999014542.SGD","LU1861215975.USD","LU1064131342.USD","LU2129689431.USD","DTCR","LU1316542783.SGD","IE000MB6IJN5.SGD","SGXZ57979304.SGD","LU0648001328.SGD","LU1670711040.USD","BK4515","LU1778281490.HKD","LU1803068979.SGD","LU0432979614.USD","SG9999001176.USD","LU1023059063.AUD","LU1691799644.USD","LU1201861249.SGD","LU0106261372.USD","LU0310800379.SGD","LU0878866978.SGD","WISE","LU0320765489.SGD","LU2106854487.HKD","BK4503","IE000BZT7R73.USD","BK4551","BK4592","LU2491050071.SGD","LU0965509101.SGD","BK4559","IE00BD6J9T35.USD","IE00BSNM7G36.USD","LU1244550221.USD","LU2491050154.USD","LU0312595415.SGD","LU0820561909.HKD","LU1303367103.USD","BK4532","MRNA","SG9999015978.USD","LU2112291526.USD","LU1093756168.USD","LU2552382058.USD","XDAT","CLOU","IE00B19Z3B42.SGD","LU1150488135.SGD","BK4560","LU0477156953.USD","LU0823421416.USD","LU2089984988.USD","LU2237443382.USD","LU0211328371.USD","BK4183","IE00B775SV38.USD","LU0203347892.USD","LU0265550946.USD","LU2089283258.USD","LU0238689110.USD","LU1169589451.USD","IYH","LU2237443895.HKD","LU1989764748.USD","FDTX","BBH","GNOM","LU0068578508.USD","LU1057294990.SGD","SG9999015945.SGD","IE0000B7K699.USD","LU0127658192.USD","LU2360108059.USD","04332","LU1066053197.SGD","LU0957808578.USD","IBBQ","LU1929549753.HKD","BK4512","SG9999014039.USD","LU1267930490.SGD","LU2237443549.SGD","MRVL","LU0069063385.USD","LU2290526834.HKD","IE00BLSP4452.SGD","WDAY","LU1116320901.HKD","IE00BZ9MQY76.HKD","LU2360032135.SGD","LU2324357040.USD","LU2360106780.USD","LU1989773731.SGD","LU0861579265.USD","LU1551013425.SGD","LU1037948897.HKD","LU0823421333.USD","AIFD","LU2125154935.USD","LU2473716301.USD","LU2360107168.USD","LU0985320562.USD","LU0823411888.USD","LU0950375773.USD","SG9999015341.SGD","LU0456855351.SGD","MRNY","LU0965509010.AUD","LU0689626769.HKD","LU0942090050.USD","BK4535","LU0128525689.USD","SG9999013999.USD","LU0077335932.USD","IE00BGHQF631.EUR","MRVU","LU1261432733.SGD","LU0211327993.USD","LU2461242641.AUD","LGHT","LU1244550494.USD","BIB","SG9999000418.SGD","LU1119994496.HKD","LU0912757837.SGD","LU2092937221.SGD","LU0289739699.SGD","BK4114","LU2506951958.HKD","LU1712237335.SGD","LU0256863902.USD","LU0444971666.USD","WCBR","BK4598","IE00B5949003.HKD","LU1551013342.USD","BK4604","LU1923622614.USD","LU2433249047.HKD","LU0203345920.USD","BK4543","IE00BMPRXR70.SGD","LU1935042991.SGD","LU1815336760.USD","LU2125909247.SGD","LU1150488218.USD","IE00BJT1NW94.SGD","SG9999014559.SGD","LU2355687059.USD","LU2237443978.SGD","SNOY","LU1548497426.USD","LU2357627491.SGD","LU2125909916.SGD","HCA","LU1934455863.HKD","LU2286300806.USD","IE00B42XCP33.USD","SG9999014575.USD","LU2250418816.HKD","LU0210528500.USD","LU0130102774.USD","LU0949170772.SGD","LU0417517546.SGD","LU1951200564.SGD","LU1035773651.USD","LU1046421795.USD","LU0265550359.USD","SG9999014013.SGD","LU1496350171.SGD","LU0234570918.USD","LU2125909759.SGD","FXL","LU2931357623.SGD","LU1839511570.USD","IE00B19Z9Z06.USD","LU1037948541.HKD","LU1923623000.USD","IHF","LU0724618433.USD","LU0122379950.USD","BK4588","IE00BVYPNW00.USD","LU1989763005.USD","LU1093756325.SGD","FTXH","LU1989771016.USD","LU1430594728.SGD","SG9999011175.SGD","LU2404859667.USD","SPAM","BK4505","WDNA","LU0289961442.SGD","LU2491049909.HKD","LU0661504455.SGD","LU2237443622.USD","LU1974910355.USD","LU2041044095.USD","BK4596","LU0124384867.USD","SG9999002224.SGD","PAWZ","LU2361044949.HKD","EL","LU0130517989.USD","LU1923622291.USD","CIBR","LU1674673428.USD","RXL","IE00BBT3K403.USD","AMGN","IE0009356076.USD","LU2098885051.SGD","LU1069347547.HKD","SG9999003800.SGD","LU0689472784.USD","LU2552382215.SGD","LU0187121727.USD","LU2211815571.USD","MVLL","IE00BFTCPJ56.SGD","BK4558","LU2242646821.SGD","LU0795875169.SGD","LU0708994859.HKD","LU1983299246.USD","LU2023250504.SGD","LU0820561818.USD","SNOU","LU1978683503.SGD","MRK","XNTK","LU1718418525.SGD","IE00BKVL7J92.USD","LU0289739343.SGD","WOLF","BK4548","HAKY","IE0002270589.USD","LU0128525929.USD","BK4607","LU2242652126.USD","LU0965509283.SGD","SG9999001440.SGD","LU1571399168.USD","LU2347655156.SGD","SG9999015952.SGD","LU2237438978.USD","LU2264538146.SGD","IE00BZ1G4Q59.USD","LU0889565833.HKD","LU1988902786.USD","LU2129689514.USD","HRTS","LU0098860793.USD","LU0476273544.USD","WUGI","BK4097","LU1989772923.USD","BK4116","JDOC","LU0302445910.USD","LU0823417653.USD","GLAM","LU0310800965.SGD","LU2087621335.USD","LOW","LU2089284900.SGD","LU2517655028.SGD","LU1074936037.SGD","LU1670710661.SGD","IE00BJJMRZ35.SGD","BK4597","LU2244417387.USD","LU1116320737.USD","BILL","SG9999015358.SGD","LU2125909593.SGD","LU1992135399.USD","LU0109394709.USD","SG9999014567.USD","LU0882574055.USD","MRVX","LU0082616367.USD","LU0266013472.USD","LU0314106906.USD","ABBV","LU1917777945.USD","IBB","LU0198837287.USD","QQQA","IE00BZ199S13.USD","LU0859254822.USD","LU1861220033.SGD","IE00BLSP4239.USD","IE00BMPRXN33.USD","IE000WAW04H5.SGD","LU1941712264.USD","LU2506952170.USD","LU1623119135.USD","LU2552382132.HKD","LU2089985449.USD","BK4613","MEDX","AIS","LU2272731600.USD","LU0053666078.USD","MRNX","LU1169590202.USD","LU1823568750.SGD","LU0690374615.EUR","PBE","LU0124676726.USD","BUG","IXJ","BK4550","LU0786609619.USD","LU1267930227.SGD","BK4533","BK4585","LU2543165471.USD","LU2487616109.SGD","BMED","LU0395794307.EUR","LU2506952097.USD","LU2458330243.SGD","SG9999002232.USD","BK4083","LU1066051498.USD","LU2272731782.SGD","LU1061106388.HKD","BK4185","LU0006306889.USD","LU0642271901.SGD","FAI","LU0823417737.USD","LU1585245621.USD","PPH","IE0002141913.USD","LU2506951875.HKD","LU0114720955.EUR","SOXY","LU0433182093.SGD","CLOD","LU0985489474.SGD","LU2517655374.HKD","LU0472753341.HKD","LU0868494617.USD","LU2023250843.SGD","LU1003077747.HKD","GDOC","IE000F7OJYX1.SGD","VHT","CRWC","LU0208291251.USD","LU2272731865.HKD","LU2404859741.USD","GTEK","TGT","IE00B2B36J28.USD","AIPI","LU0256863811.USD","LU0109392836.USD","BK4007","LU0094547139.USD","IE00B19Z9P08.USD","BK4501","LU0943347566.SGD","FTXL","IHE","LU0056508442.USD","LU0795875086.SGD","LU1852331112.SGD","LU1642822529.SGD","IE00B1BXHZ80.USD","BK4155","LU1861214812.USD","LU0444973449.USD","LU0823434740.USD","BK4516","SMHX","IE00B3PB1722.GBP","LU2361044865.SGD","LU2322448791.USD","LU2133065610.SGD","DAT","LU1861219969.SGD","IE00BVYPNV92.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660747701","title":"復宏漢霖盤中漲近8% 近期聯手山德士出海至多10款生物類似藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747701","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747701?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 10:56","pubTimestamp":1787194560,"startTime":"0","endTime":"0","summary":"模拟交易客户端复宏汉霖盘中涨近8%,截至发稿,股价上涨6.87%,现报70.05港元,成交额1646.58万港元。基于上述首批约定,山德士将向复宏汉霖支付首付款、相关里程碑付款及不可退还的选择权费共计至高3.22亿美元;2026年,复宏汉霖预计可达成的开票金额总计不超过1.005亿美元。值得一提的是,海外市场已成为复宏汉霖业绩增长的重要组成部分。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-20/doc-ininxqxw2099208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2322448791.USD","LU2322448957.HKD","HK0000306701.USD","LU2272731600.USD","IBB","BK1161","BK4588","HK0000320264.USD","LU2272731865.HKD","PPH","02696","HK0000320223.HKD","HK0000165453.HKD","LU1992135399.USD","BK4585","IE00B5TLWC47.USD","LU1992135472.HKD","LU2272731782.SGD","HK0000306685.HKD","XPH","LU2473716301.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473644","title":"福泰製藥(VRTX)股票8月19日收盤上漲4.48%:釋放什麼信號?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473644","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473644?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 04:16","pubTimestamp":1787170582,"startTime":"0","endTime":"0","summary":"• 在竞争对手临床试验宣告失败后,福泰制药股价飙升至历史新高。\n• 第二季度营收超出预期,公司同时上调了全年业绩指引。\n• 分析师纷纷给出看涨评级,平均目标价达 563.25 美元。","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262119125-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2237438978.USD","TBXU","BBH","LU1035775433.USD","LU0417517546.SGD","LU2324357040.USD","LU0823416689.USD","IBB","LU1674673691.USD","LU2462157665.USD","LU2362541513.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","BK4567","GNMX","LU0256863811.USD","LU1093756325.SGD","LU2417539215.USD","LU0058720904.USD","IBBQ","IE0002270589.USD","LU1674673428.USD","LU1778281490.HKD","LU0234570918.USD","LU0289739699.SGD","LU1069344957.HKD","LU2236285917.USD","LU2362541273.HKD","IE00B19Z9P08.USD","LU2456880835.USD","BK4139","PBE","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00B19Z9Z06.USD","LU1585245621.USD","VRTX","LU0109394709.USD","IDNA","LU0432979614.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","BIB","LU0320765992.SGD","LU0079474960.USD","SG9999001176.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660113478","title":"吉利德科學(GILD)股票8月19日盤中上漲3.66%:背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660113478","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660113478?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 03:17","pubTimestamp":1787167048,"startTime":"0","endTime":"0","summary":"• 得益于HIV产品组合增长加速,吉利德上调了全年销售指引。\n• 联邦法院颁布禁令阻止海外进口,以保护其核心市场份额。\n• 分析师给予“买入”评级,平均目标价为157.79美元。","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118864-market-movers-gild-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU0289739699.SGD","LU1934455863.HKD","LU1934455194.USD","BK4583","LU0965509283.SGD","GILD","BK4532","LU0320765992.SGD","LU1023059063.AUD","LU2324357040.USD","MEDI","LU1674673691.USD","BK4139","BK4588","LU1778281490.HKD","LU0058720904.USD","BIB","IE0002270589.USD","LU0965509010.AUD","SG9999015978.USD","LU1839511570.USD","LU0234570918.USD","TMED","LU1674673428.USD","LU0823416689.USD","LU1066051498.USD","SG9999015986.USD","IE00BKVL7J92.USD","LU2468319806.SGD","IE00B19Z3581.USD","BK4550","BBH","BMED","BK4568","SG9999015952.SGD","BK4578","LU1585245621.USD","IE00BZ1G4Q59.USD","LU1934455277.USD","IBB","LU1037948541.HKD","LU0965508806.USD","LU1057294990.SGD","LU0965509101.SGD","TBXU","IE00BSNM7G36.USD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660819420","title":"安進(AMGN)股票8月19日盤中上漲3.19%:背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660819420","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660819420?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 02:16","pubTimestamp":1787163383,"startTime":"0","endTime":"0","summary":"• Argus上调安进目标价,并重申“买入”评级。\n• 第二季度财务业绩超出华尔街的营收和盈利预期。\n• 技术指标显示 MACD 买入信号及 RSI 买入条件。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118749-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00B2B36J28.USD","AMGN","IE0002141913.USD","LU2112291526.USD","LU1023059063.AUD","IBBQ","LU1571399168.USD","PJP","BBH","TBXU","BIB","BK4588","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2242646821.SGD","IE00B4R5TH58.HKD","IBB","LU0058720904.USD","LU0122379950.USD","LU0289739699.SGD","LU2468319806.SGD","BK4599","LU1983299246.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0889565916.HKD","BK4139","LU1057294990.SGD","PBE","LU0109394709.USD","LU0320765992.SGD","LU1061106388.HKD","LU0868494617.USD","BK4533","BK4581","SG9999001440.SGD","LU2089984988.USD","BK4566","BK4585","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105025052","title":"再生元製藥旗下Pasatru獲歐洲藥品管理局審評,全球申報在即","url":"https://stock-news.laohu8.com/highlight/detail?id=1105025052","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105025052?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 02:00","pubTimestamp":1787162410,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布,其研发的药物Pasatru已被欧洲药品管理局纳入审评流程。与此同时,该公司正积极筹备在全球范围内提交该药物的上市申请。欧洲药品管理局的审评启动,为这款药物在欧洲地区的获批前景增添了重要砝码。业界分析认为,Pasatru若能顺利通过审评,有望为相关疾病领域带来新的治疗选择。再生元制药在创新药物研发领域深耕多年,此次针对Pasatru的全球布局,也彰显了其对这一候选药物商业潜力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU2468319806.SGD","LU0114720955.EUR","LU0823434583.USD","LU0320765992.SGD","LU0109394709.USD","LU2362541273.HKD","IBB","BK4585","LU2362540622.SGD","TBXU","LU0823434740.USD","LU0823416689.USD","BK4139","REGN","BK4588","LU0058720904.USD","LU2362541513.USD","LU1974910355.USD","LU2023250504.SGD","BBH","LU0882574055.USD","LU0053666078.USD","LU2106854487.HKD","LU2089984988.USD","LU0889565916.HKD","IBBQ","LU1917777945.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188134905","title":"再生元製藥獲FDA批准:Pasatru(Garetosmab-Grts)上市,治療成人進行性骨化性纖維發育不良","url":"https://stock-news.laohu8.com/highlight/detail?id=1188134905","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188134905?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 01:59","pubTimestamp":1787162353,"startTime":"0","endTime":"0","summary":"再生元制药公司今日宣布,其研发的新药Pasatru已获得美国食品药品监督管理局的正式批准,用于治疗成人进行性骨化性纤维发育不良。这一罕见疾病此前一直缺乏有效的治疗手段,此次获批为患者带来了新的希望。FDA的此次批准基于多项临床研究数据,结果显示Pasatru在减缓异位骨化进展方面表现出显著疗效,且安全性可控。未来,再生元制药计划进一步拓展Pasatru的适应症范围,并探索其在其他相关疾病中的潜在应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU2362541513.USD","BK4139","LU2089984988.USD","LU0289739699.SGD","REGN","LU0823434583.USD","LU0053666078.USD","LU2362541273.HKD","BK4588","IBBQ","BBH","TBXU","LU0114720955.EUR","LU2362540622.SGD","LU0882574055.USD","LU2468319806.SGD","LU0109394709.USD","LU2237438978.USD","BK4585","LU2106854487.HKD","LU0823416689.USD","LU2023250504.SGD","LU0823434740.USD","LU0889565916.HKD","IBB","LU1974910355.USD","LU0320765992.SGD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187101531","title":"異動解讀|生物科技指數ETF-iShares Nasdaq盤中上漲5.1%,MNC併購加速疊加多重利好共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1187101531","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187101531?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 22:09","pubTimestamp":1787148587,"startTime":"0","endTime":"0","summary":"8月19日,生物科技指数ETF-iShares Nasdaq盘中上涨5.1%,报213.88美元,成交额1.03亿美元。消息面上,生物科技板块近期迎来多重利好共振。另一方面,AI制药订单持续落地驱动生命科学上游需求攀升,板块整体景气度回暖。此外,再生元Libtayo获加拿大卫生部批准用于高危皮肤鳞状细胞癌辅助治疗,进一步提振市场情绪。该ETF追踪纳斯达克生物医疗指数,包含在纳斯达克上市的生物医疗公司,成分和权重可能随时间变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660585446","title":"瑞穗上調安進目標價至352美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660585446","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660585446?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:55","pubTimestamp":1787129710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BBH","LU1571399168.USD","LU1023059063.AUD","TBXU","BK4581","BK4139","IE00BFTCPJ56.SGD","BK4534","LU2112291526.USD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","BK4588","PJP","LU2242652126.USD","LU0868494617.USD","SG9999001440.SGD","UUP","IBB","LU0122379950.USD","BK4566","LU2089984988.USD","BK4533","UDN","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BIB","BK4585","LU1061106388.HKD","LU1983299246.USD","LU2242646821.SGD","PBE","LU0320765992.SGD","LU0058720904.USD","LU1057294990.SGD","AMGN","LU0289739699.SGD","IE0009355771.USD","BK4599","IE0002141913.USD","IBBQ","IE00BJJMRZ35.SGD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431564","title":"駿利亨德森投資:專利到期倒逼藥企擴張 生物科技併購、IPO市場同步復甦","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431564","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431564?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:06","pubTimestamp":1787126785,"startTime":"0","endTime":"0","summary":"骏利亨德森投资称,尽管利率较市场年初的预期为高,但生物科技行业交易活动的增长动力持续不减。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BIS","IWO","QSML","IYG","MRNY","PBE","BBC","IJT","SPCK","BIB","IBBJ","IAI","BK4582","IBB","FBT","BBP","JDOC","MRNX","BK4585","BK4588","GTPE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660416851","title":"藥代違規進入診療區域!湘雅二醫院發藥品「停用函」,艾力斯、賽諾菲、安進、康蒂尼四藥企上「黑榜」","url":"https://stock-news.laohu8.com/highlight/detail?id=2660416851","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660416851?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 09:48","pubTimestamp":1787104101,"startTime":"0","endTime":"0","summary":"湘雅二医院方面向澎湃新闻表示,院方确有发该“协办函”。据此次公布的协办函,对几家涉事药企的处理决定颇为严厉。近年来,医药代表违规已不仅是行业道德问题,而是监管重点。此次湘雅二医院将企业列入购销负面清单,正是医院端落地上述政策的缩影。湘雅二医院相关负责人表示,自国家在2020年底建立医药代表备案制度,医院就积极响应国家政策,并不断完善内部制度和执行流程。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787103396417327872","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0289739699.SGD","LU2468319806.SGD","BIB","BBH","AMGN","SG9999001440.SGD","TBXU","LU0889565916.HKD","688578","LU0320765992.SGD","LU2242646821.SGD","IE00BJT1NW94.SGD","BK4534","BK0239","BK4139","BK4585","IE0002141913.USD","BK4533","IBB","IE00BFTCPJ56.SGD","LU1983299246.USD","LU0868494617.USD","BK4581","LU2242652126.USD","PBE","BK4588","IE00B2B36J28.USD","BK4566","IE0009355771.USD","LU1057294990.SGD","PJP","LU2112291526.USD","IE00B4R5TH58.HKD","BK4599","LU1023059063.AUD","LU2089984988.USD","LU1571399168.USD","LU0058720904.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU0109394709.USD","LU0122379950.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192416297","title":"TScan Therapeutics披露:安進將終止與其研究合作及許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1192416297","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192416297?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 05:04","pubTimestamp":1787087050,"startTime":"0","endTime":"0","summary":"值得注意的是,安进作为全球领先的生物制药公司,此举无疑将对TScan Therapeutics的研发管线及未来战略布局产生深远影响。TScan Therapeutics方面表示,将仔细评估这一变化对公司在研项目及整体运营带来的潜在影响。对于TScan Therapeutics而言,此番变故或许意味着需要重新校准其研发路径,并探索新的合作机会或资金来源以继续推进其创新疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LU2242652126.USD","LU1983299246.USD","PJP","IE0009355771.USD","LU2468319806.SGD","LU2089984988.USD","LU0320765992.SGD","BK4588","AMGN","IBB","TBXU","LU2242646821.SGD","LU0868494617.USD","TCRX","PBE","BK4534","LU0058720904.USD","IBBQ","LU0109394709.USD","BK4581","BK4599","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU1061106388.HKD","IE00BJT1NW94.SGD","BK4533","LU1571399168.USD","LU2112291526.USD","IE0002141913.USD","BIB","LU0289739699.SGD","LU1023059063.AUD","IE00B2B36J28.USD","BK4139","LU1057294990.SGD","SG9999001440.SGD","BBH","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0122379950.USD","BK4585","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491619","title":"吉利德科學(GILD)股票8月18日盤中上漲3.14%:背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491619","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660491619?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 02:16","pubTimestamp":1787076999,"startTime":"0","endTime":"0","summary":"• 联邦法院禁令阻止了吉利德关键HIV药物的海外进口。\n• 强劲的基础业务营收增长与上调业绩指引提振了市场乐观情绪。\n• 肿瘤领域的战略投资及机构看涨期权活动的活跃支撑了股价的上涨势头。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262115765-market-movers-gild-20260818","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1037948541.HKD","LU1778281490.HKD","BK4583","LU1430594728.SGD","BK4578","IE00BKVL7J92.USD","LU1585245621.USD","IE00B7SZLL34.SGD","LU0109394709.USD","BIB","IBB","TMED","IE00B19Z3B42.SGD","LU1023059063.AUD","LU1674673691.USD","LU0823416689.USD","LU1061106388.HKD","BK4566","SG9999015986.USD","LU1674673428.USD","LU2324357040.USD","BMED","LU0320765992.SGD","IBBQ","BK4585","IE00B19Z3581.USD","LU1066053197.SGD","SG9999015952.SGD","LU0965509101.SGD","LU0289739699.SGD","LU0114720955.EUR","LU1934455863.HKD","LU0965508806.USD","LU1037948897.HKD","BK4550","LU2087621335.USD","LU1839511570.USD","LU0058720904.USD","BBH","LU1571399168.USD","GILD","MEDI","SG9999015978.USD","IE00BSNM7G36.USD","IE00B3T34201.USD","TBXU","LU2112291526.USD","IE00BZ1G4Q59.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660439442","title":"argenx SE(ARGX)股票8月17日盤中上漲16.67%:關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2660439442","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660439442?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 00:16","pubTimestamp":1786983373,"startTime":"0","endTime":"0","summary":"• Argenx 宣布其药物 VYVGART Hytrulo 在治疗肌炎的 3 期 ALKIVIA 研究中取得积极结果。\n• 该公司公布全年营收为 41.5 亿美元,净利润为 12.9 亿美元。\n• 分析师给予“买入”评级,平均目标价为 1083.77 美元。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262112725-market-movers-argx-20260817","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX","LU0823416689.USD","IE00B4R5TH58.HKD","BK4588","IE00B2B36J28.USD","LU1983260115.SGD","IE0034235188.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4505","IE0009355771.USD","IBB","BK4585","FMED","BK4139","LU0889565916.HKD","IE0002141913.USD","LU2324357040.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","TBXU","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660332334","title":"EyePoint股價料將創下歷史最大跌幅,因其一款實驗性眼科藥物未能達到後期臨床試驗目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2660332334","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660332334?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 22:15","pubTimestamp":1786976114,"startTime":"0","endTime":"0","summary":"BUZZ-EyePoint股价料将创下历史最大跌幅,因其一款实验性眼科药物未能达到后期临床试验目标最新动态8月17日-**EyePoint公司(EYPT.O)股价暴跌71%至4.17美元,有望创下有史以来最大单日跌幅,并跌至2025年4月以来的最低点**这家药物开发商表示,其实验性眼科药物Duravyu在针对湿性年龄相关性黄斑变性(视力丧失的主要原因之一)患者开展的晚期临床试验中,未能达到主要目标","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E101:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","EYPT","LU2468319806.SGD","LU0320765992.SGD","LU0114720955.EUR","TBXU","IBB","BK4007","LU2023250504.SGD","LU0823434740.USD","LU0823434583.USD","LU1917777945.USD","LU1974910355.USD","LU0058720904.USD","BK4585","IBBQ","BK4588","LU2362541273.HKD","LU2237438978.USD","BBH","LU0823416689.USD","LU0889565916.HKD","LU0882574055.USD","REGN","LU2106854487.HKD","LU2362541513.USD","LU0289739699.SGD","LU2362540622.SGD","BK4139","LU0109394709.USD","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137019504","title":"美股開盤 | 三大指數升跌不一,閃迪升逾3%,Argenx SE漲近9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137019504","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137019504?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 21:32","pubTimestamp":1786973544,"startTime":"0","endTime":"0","summary":"8月17日,美股三大指数开盘涨跌不一,道琼斯指数跌0.23%,标普500指数涨0.04%,纳斯达克综合指数涨0.24%。美股存储股普涨,SK海力士、西部数据、闪迪涨超3%,美光科技、希捷科技涨超2%。OmniAb涨超23%,公司此前宣布与礼来达成3.7亿美元药物研发协议。Argenx SE涨近9%,Efgartigimod治疗肌炎III期试验成功。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4141","LU0240877869.USD","WDCX","SCHA","SG9999018857.SGD","LU2360107168.USD","SKHYV","LU1035775433.USD","JDOC","LU1069347547.HKD","LU2087625088.SGD","LU1093756325.SGD","LU2111349929.HKD","LU0316494557.USD","SG9999015952.SGD","LU0476273544.USD","LU0823434583.USD","LU0471298694.HKD","LU0889565833.HKD","LU2112291526.USD","IBB","LU2357305700.SGD","LU2271345857.HKD","BK4512","BK4575","FDTX","LU2756315318.SGD","SMAX","SG9999014880.SGD","LU0456855351.SGD","TTXU","IE00BJJMRX11.SGD","LU0109394709.USD","LU1988902786.USD","LU2750360997.AUD","HBMX","TRFK","BK4543","FXL","FSMD","AIS","LU1804176565.USD","LU1366192091.USD","LU2168563687.JPY","BK4554","SMU00main","LU2552382132.HKD","LU0444971666.USD","DXD","LU0109391861.USD","LU0719512351.SGD","YSPY","LU2931357623.SGD","EFIV","AIQ","IE00BJLML261.HKD","DISK","LU2213496289.HKD","LU2491050071.SGD","AGNG","LU0096364046.USD","IE00B1BXHZ80.USD","LU2361044949.HKD","LU0964807845.USD","IE00B894F039.SGD","LU1093756168.USD","LU2237438978.USD","IE0002270589.USD","LU2023251221.USD","XLK","LU2746668974.SGD","FCUS","LLYZ","GB00BDT5M118.USD","LU1974910355.USD","ELIS","VOO","LU2361044865.SGD","LU2458330243.SGD","MUZ","LU0708995401.HKD","PSI","LU0466842654.USD","LU0256863902.USD","PPH","LU1280957306.USD","VHT","MIC","LU2237443622.USD","LU0133085943.USD","LU2250418816.HKD","LU0072461881.USD","SKHA","DDM","SG9999017495.SGD","SPXS","LU2417539215.USD","LU2168564065.EUR","LU2471134952.CNY","LU2462591350.SGD","LU1712237335.SGD","IE0004445015.USD","CANC","IE00BWXC8680.SGD","LU0056508442.USD","LU0058720904.USD","IE00B19Z9P08.USD","LU1232071149.USD","LU1291159041.SGD","LU1868837136.USD","LU0289739699.SGD","SG9999015978.USD","PJP","SG9999013999.USD","SPYU","LU0094547139.USD","LU1064131342.USD","LU2236285917.USD","LU2063271972.USD","LU2471134796.USD","LU1868836591.USD","LU1852331112.SGD","SK","HIBL","SNDK","LLYX","TMED","LU0471298777.SGD","BK4139","TRUH","SGXZ81514606.USD","IE0034235303.USD","LU2089283258.USD","IE00B1XK9C88.USD","SGXZ51526630.SGD","LU0354030438.USD","BK4579","SOXQ","LU1674673428.USD","LU2896262040.SGD","BK4566","LU2403377893.USD","LU0079474960.USD","LU2468319806.SGD","LU0882574139.USD","SPDN","SSO","LU0353189763.USD","IE00B19Z3581.USD","LU1548497426.USD","XLV","LU1267930813.SGD","LLY","IE00B775H168.HKD","LU0225283273.USD","LU2456880835.USD","COWG","LU2265009873.SGD","LU2089985449.USD","OZEM","MUYY","LU0157215616.USD","IE0005OL40V9.USD","LU1720051108.HKD","LU1803068979.SGD","LU1917777945.USD","LU0444973449.USD","STX.AU","LU2756315664.SGD","ARGX","LU2237443549.SGD","LU0203202063.USD","LU2290526834.HKD","IE00B4R5TH58.HKD","LU0174119429.USD","SMH","IE0002141913.USD","LU2168564222.USD","RULE","CNAV","LLII","LU1868836914.USD","LU1815336760.USD","LU2552382215.SGD","LU2237443465.HKD","LU1069344957.HKD","IE0001KFT4U8.USD","IE00B7SZLL34.SGD","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","LU1670628061.USD","LU1057294990.SGD","SPXU","SH","LU2471134879.HKD","LU1823568750.SGD","LU0097036916.USD","LU2023250504.SGD","IE00B19Z3B42.SGD","LU2102340556.USD","MMAX","LU2746668461.USD","LU2237443382.USD","SG9999001176.SGD","CGGO","IXN","IE0009355771.USD","LU0006061336.USD","SPY","LU1127390331.HKD","IETC","LU0081259029.USD","LU0234572021.USD","SGXZ99366536.SGD","LU2357627491.SGD","LU2491050154.USD","BK4585","SG9999018865.SGD","XNTK","LU2264538146.SGD","LU0792757196.USD","LU0006306889.USD","FTEC","LU1267930730.SGD","SKHX","LU0054578231.USD","WDC","SG9999015945.SGD","LU1674673691.USD","BK4581","LU0859254822.USD","USXF","BK4527","LU1983299246.USD","CHPS","SGXZ57979304.SGD","IE00B4JS1V06.HKD","IE00BJJMRZ35.SGD","LU0323591593.USD","BK4533","YMmain","FHLC","HYNX","LU0786609619.USD","LU2108987350.USD","MULL","SKUU","WDNA","SG9999001176.USD","DMAX","LU0082616367.USD","LU0158827781.USD","BK4516","LU0210536198.USD","MUU","QQQA","MU","07709","LU0432979614.USD","IE0004445239.USD","IE0009356076.USD","LU2750360641.GBP","SKDD","UDOW","LU1861220033.SGD","LU1316542783.SGD","IE00B2B36J28.USD","LU0345770993.USD","SKHY","LU0114720955.EUR","LU0689472784.USD","LU1861215975.USD","DOG","LU0963586101.USD","LU0203345920.USD","QQQG","LU2543165471.USD","IHE","LU1989764664.SGD","IE00BK4W5L77.USD","LU2552382058.USD","BK4170","IE00BJJMRY28.SGD","WLDR","FMED","LU2237443895.HKD","LU0640476718.USD","LU1551013425.SGD","CURE","SNDC","SNXX","ILDR","SNDU","IE00BFTCPJ56.SGD","LU2237443978.SGD","LU0240878834.USD","FAI","LU0238689110.USD","LU1046421795.USD","LU2168564495.EUR","LU2286300806.USD","SG9999014898.SGD","LU2491049909.HKD","LU1061106388.HKD","LU2360106780.USD","LU0820562030.AUD","FTXH","STX","LU1623119135.USD","LU0266013472.USD","SPUU","LU0203201768.USD","WUGI","GDOC","SDS","IYH","LU2023250330.USD","IE00B5949003.HKD","SGXZ31699556.SGD","LU0198837287.USD","LU0882574055.USD","LU2089984988.USD","IXJ","LU0417517546.SGD","UPRO","LU0683600562.USD","LU0154236417.USD","LU1366333091.USD","LU2461242641.AUD","SKHU","LU0345770308.USD","SNDG","LU0106261372.USD","LU0127658192.USD","FTXL",".IXIC","BOBP","SOXX","CHAT","SHOC","LU1989771016.USD","LU1642822529.SGD","LU1814569148.SGD","IE00BKDWB100.SGD","LU1868836757.USD","MEDX","BK4599","LU2458330169.SGD","LU1979441026.SGD","LU0823434740.USD","LU0820561818.USD","VGT","LU2471134523.USD","RXL","LU1983260115.SGD","MEDI","LU0203347892.USD","BK7142","LU0061475181.USD","LU0672654240.SGD","IVV","BK4532","LU1551013342.USD","LU0943347566.SGD","SPYM","LU2089284900.SGD","LU0642271901.SGD","IE00BFSS7M15.SGD","LU2054465674.USD","TMSL","IE00BFSS8Q28.SGD","BK4553","DIA","LU2028103732.USD","LU1145028129.USD","LU0353189680.USD","BK4505","SG9999015986.USD","IE00BKPKM429.USD",".DJI","EGGY","LU2361045086.USD","LU2324357040.USD","LU1989764748.USD","CNEQ","BK4588","LU1023059063.AUD","BK4007","LU0122379950.USD","SG9999014914.USD",".SPX","LU2048586759.USD","PTF","SPXL","LU0256863811.USD","SPYH","LU1720051017.SGD","HRTS","DRMY","LU1778281490.HKD","LU1629891620.HKD","LU0957808578.USD","LU2211815571.USD","BK4534","ELIL","IE00B7KXQ091.USD","LU0823416689.USD","LEGR","LU0320765059.SGD","IE0034235188.USD","LU0354030511.USD","LU0820561909.HKD","ARTY","LU0889566641.SGD","LU1323610961.USD","LU0385154629.USD","LU1035773651.USD","LU0787776722.HKD","LU0158827948.USD","JGRO","LU1670627923.USD","LU0162691827.USD","IE00BN29S564.USD","CHPX","LU1914381329.SGD","SNDQ","LU1868837300.USD","SKHZ","TBXU","LU2462157665.USD","SCHM","AIFD","EMSF","BAI","LU2168564149.EUR","LU0109392836.USD","SG9999014906.USD","SPYQ","LU0320765992.SGD","LU0274383776.USD","LU2602419157.SGD","BK4605","LU1235294995.USD","LU0889565916.HKD","SDOW","OPTZ","IE000M9KFDE8.USD","IE00BK4W5M84.HKD","SG9999001424.SGD","THNR","MUD","MHIP","LU2360106947.USD","LU2106854487.HKD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660848445","title":"EyePoint公司治療年齡相關性眼病的藥物晚期臨床試驗失敗,股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2660848445","media":"路透中文","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660848445?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 19:14","pubTimestamp":1786965255,"startTime":"0","endTime":"0","summary":"EyePoint公司未能证明Duravyu在保护视力方面不比Eylea明显逊色。而在接受Eylea治疗的患者中,未出现此类情况。EyePoint的股价在早盘交易中跌至4.16美元。EyePoint计划于2027年上半年向美国FDA提交批准申请,具体取决于预计于今年晚些时候公布的第二项晚期临床试验结果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E0O1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU0289739699.SGD","REGN","IBB","LU0823434740.USD","LU0114720955.EUR","LU2362541513.USD","TBXU","OTLK","LU2362540622.SGD","LU0320765992.SGD","LU0889565916.HKD","LU0053666078.USD","LU2089984988.USD","LU0882574055.USD","LU0823434583.USD","BBH","LU2023250504.SGD","BK4585","LU0058720904.USD","IBBQ","EYPT","LU2237438978.USD","BK4139","LU2106854487.HKD","BK4588","LU0823416689.USD","LU1917777945.USD","BK4007","LU0109394709.USD","LU1974910355.USD","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660481020","title":"美股異動 | Argenx(ARGX.US)盤前升逾10% 自身免疫性肌炎藥物Vyvgart III期研究達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2660481020","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660481020?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 18:48","pubTimestamp":1786963699,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4134","IE00B2B36J28.USD","BK4585","IE00BFTCPJ56.SGD","LU0109394709.USD","ARGX","IE0002141913.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","BK4588","IE0034235188.USD","LU0889565916.HKD","III","BK4139","LU2324357040.USD","FMED","IBB","IE00BJT1NW94.SGD","BK4505","LU1983260115.SGD","LU0823416689.USD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":148,"code":"91000000","status":"200"}]}}